Skip to main navigation Skip to search Skip to main content

Pretreatment factors associated with symptomatic stroke in Moyamoya disease patients: A multicenter study

  • Basel Musmar
  • , Joanna M. Roy
  • , Hamza Adel Salim
  • , Anand Kaul
  • , Elias Atallah
  • , Kareem El Naamani
  • , Ching Jen Chen
  • , Roland Jabre
  • , Hassan Saad
  • , Jonathan A. Grossberg
  • , Adam A. Dmytriw
  • , Aman B. Patel
  • , Mirhojjat Khorasanizadeh
  • , Christopher S. Ogilvy
  • , Ajith J. Thomas
  • , Andre Monteiro
  • , Adnan Siddiqui
  • , Gustavo M. Cortez
  • , Ricardo A. Hanel
  • , Guilherme Porto
  • Alejandro M. Spiotta, Anthony J. Piscopo, David M. Hasan, Mohammad Ghorbani, Joshua Weinberg, Shahid M. Nimjee, Kimon Bekelis, Mohamed M. Salem, Jan Karl Burkhardt, Akli Zetchi, Charles Matouk, Brian M. Howard, Rosalind Lai, Rose Du, Rawad Abbas, Georgios S. Sioutas, Abdelaziz Amllay, Alfredo Munoz, Nabeel A. Herial, Stavropoula I. Tjoumakaris, Michael Reid Gooch, Robert H. Rosenwasser, Pascal Jabbour
  • Thomas Jefferson University
  • University of Arizona
  • University of Texas Health Science Center at Houston
  • Emory University
  • University of Toronto
  • Harvard University
  • Cooper University Health Care
  • SUNY Buffalo
  • Baptist Health
  • Medical University of South Carolina
  • University of Iowa
  • Duke University
  • Firoozgar Hospital
  • Ohio State University
  • Good Samaritan Hospital Medical Center
  • University of Pennsylvania
  • Yale University

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Objectives: Moyamoya disease (MMD) is a cerebrovascular disorder marked by the progressive steno-occlusion of the bilateral internal carotid arteries and the formation of abnormal collateral vessel networks at the base of the brain. Previous studies have attempted to identify risk factors predictive of postoperative complications to improve patient management. This study aims to identify pretreatment factors associated with post-bypass symptomatic strokes in MMD patients. Methods: This study is a multicenter retrospective analysis conducted across 13 academic institutions in North America. A total of 518 patients with MMD were included. Data collected included patient demographics, disease characteristics, and follow-up duration. Stroke-free survival was analyzed using Kaplan-Meier curves. Univariate and multivariable Cox regression analyses were used to identify risk factors for symptomatic stroke. Results: The median age of the patients was 43 years (IQR, 34–52 years), and 370 (71 %) were females. Multivariable Cox regression identified advanced age (HR 1.03, 95 % CI 1.01–1.05, p = 0.011), female sex (HR 2.03, 95 % CI 1.00–4.11, p = 0.049), diabetes mellitus (HR 2.03, 95 % CI 1.14–3.63, p = 0.016), smoking status (HR 2.27, 95 % CI 1.27–4.05, p = 0.006), and asymptomatic disease (HR 0.37, 95 % CI 0.15–0.93, p = 0.034) as significant factors associated with symptomatic stroke. Conclusion: Advanced age, female sex, diabetes mellitus, and smoking status were significant predictors of symptomatic stroke in MMD patients after bypass surgery. Asymptomatic patients had a reduced risk of stroke. These findings emphasize the importance of managing modifiable risk factors and the potential benefits of early detection in improving clinical outcomes for MMD patients. Further prospective studies are needed to validate these findings.

Original languageEnglish
Article number110922
JournalJournal of Clinical Neuroscience
Volume130
DOIs
StatePublished - Dec 2024

Keywords

  • Moyamoya
  • Multicenter
  • Risk factors
  • Stroke

Fingerprint

Dive into the research topics of 'Pretreatment factors associated with symptomatic stroke in Moyamoya disease patients: A multicenter study'. Together they form a unique fingerprint.

Cite this